These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23288027)

  • 21. Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.
    Takashi Y; Kinoshita Y; Hori M; Ito N; Taguchi M; Fukumoto S
    Endocr Res; 2017 May; 42(2):132-137. PubMed ID: 27754732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of imaging to the diagnosis and follow up of X-linked hypophosphatemia.
    Adamsbaum C; Laredo JD; Briot K; Linglart A
    Arch Pediatr; 2021 Oct; 28(7):594-598. PubMed ID: 34583869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rickets/Osteomalacia. Diagnosis of tumor-induced osteomalacia.].
    Koga M; Ito N
    Clin Calcium; 2018; 28(10):1351-1357. PubMed ID: 30269117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets.
    Sun Y; Wang O; Xia W; Jiang Y; Li M; Xing X; Hu Y; Liu H; Meng X; Zhou X
    J Bone Miner Metab; 2012 Jan; 30(1):78-84. PubMed ID: 21710177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor-23 and renin-angiotensin system levels in vitamin-D-dependent rickets type I.
    Cuervo C; Abitbol CL; Zilleruelo GE; Freundlich M
    Pediatr Nephrol; 2016 Jul; 31(7):1189-93. PubMed ID: 26939683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter to the Editor: Comment on "FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival" by Thiessen S.E., et al.
    Plomgaard P; Weigert C
    J Clin Endocrinol Metab; 2015 Oct; 100(10):L102-3. PubMed ID: 26439155
    [No Abstract]   [Full Text] [Related]  

  • 27. [FGF23-related hypophosphatemic rickets/osteomalacia].
    Ito N; Fukumoto S
    Clin Calcium; 2007 Oct; 17(10):1514-20. PubMed ID: 17906402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypophosphatemia: the common denominator of all rickets.
    Tiosano D; Hochberg Z
    J Bone Miner Metab; 2009; 27(4):392-401. PubMed ID: 19504043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A compound heterozygous mutation in SLC34A3 causes hereditary hypophosphatemic rickets with hypercalciuria in a Chinese patient.
    Chi Y; Zhao Z; He X; Sun Y; Jiang Y; Li M; Wang O; Xing X; Sun AY; Zhou X; Meng X; Xia W
    Bone; 2014 Feb; 59():114-21. PubMed ID: 24246249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to letter regarding article, "fibroblast growth factor 23 and risk of incident stroke in community-living adults".
    Gutiérrez OM
    Stroke; 2015 May; 46(5):e124. PubMed ID: 25782465
    [No Abstract]   [Full Text] [Related]  

  • 31. Response to Taylor et al: comments on making the diagnosis of rickets in asymptomatic young children.
    Hyman CJ; Ayoub D; Miller M
    Clin Pediatr (Phila); 2011 May; 50(5):474. PubMed ID: 21127086
    [No Abstract]   [Full Text] [Related]  

  • 32. [Value of serum fibroblast growth factor 23 in diagnosis of hypophosphatemic rickets in children].
    Dong SS; Che RC; Zheng BX; Zhang AH; Wang CL; Bai M; Chen Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):705-710. PubMed ID: 37529952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)].
    Endo I
    Clin Calcium; 2009 Jun; 19(6):815-20. PubMed ID: 19483276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.
    Shimada T; Urakawa I; Isakova T; Yamazaki Y; Epstein M; Wesseling-Perry K; Wolf M; Salusky IB; Jüppner H
    J Clin Endocrinol Metab; 2010 Feb; 95(2):578-85. PubMed ID: 19965919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.
    Imel EA; Hui SL; Econs MJ
    J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypophosphatemic rickets in opsismodysplasia.
    Zeger MD; Adkins D; Fordham LA; White KE; Schoenau E; Rauch F; Loechner KJ
    J Pediatr Endocrinol Metab; 2007 Jan; 20(1):79-86. PubMed ID: 17315533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter by Zou and Zheng regarding article, "fibroblast growth factor 23 and risk of incident stroke in community-living adults".
    Zou L; Zheng S
    Stroke; 2015 May; 46(5):e123. PubMed ID: 25782467
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth hormone and insulin-like growth factor I plasma levels in patients with hypophosphatemic rickets.
    Jasper H; Cassinelli H
    J Pediatr Endocrinol; 1993; 6(2):179-84. PubMed ID: 8348222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two Case Reports of FGF23-Induced Hypophosphatemia in Childhood Biliary Atresia.
    Wasserman H; Ikomi C; Hafberg ET; Miethke AG; Bove KE; Backeljauw PF
    Pediatrics; 2016 Aug; 138(2):. PubMed ID: 27462066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fibroblast growth factor 23--a phosphate regulating hormone].
    Beck-Nielsen SS; Pedersen SM; Kassem M; Rasmussen LM
    Ugeskr Laeger; 2010 May; 172(20):1521-7. PubMed ID: 20483099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.